title: Comment on: Early CSF and serum S 100B concentrations for outcome prediction in traumatic brain injury and subarachoid haemorrhage.
abstract: METHODS
  In the letter the authors discuss the findings in Kellerman and co-worker's paper: Early CSF and Serum S 100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachoid Haemorrhage published in this journal. Among the findings reported in this paper is that an initial S 100B value of more than 0.7μg/l would strongly indicate a very poor prognosis. This finding is discussed.
  
  
  CONCLUSIONS
  That a use of S 100B as a prognostic tool for clinical decision making is very doubtful and should most probably be refrained from.
authors: Department of Anaesthesiology and Intensive Care, Section for Neurosurgery, Faculty of Health and Medicine, University Hospital Orebro, SE 70185, Orebro, Sweden; Department of Pharamacology and Clinical Neuroscience, Neurosurgery, Umea University, Sweden. Electronic address: Magnus.olivecrona@oru.se.
authors: Magnus
authors: M
authors: Olivecrona
authors: Department of Pharamacology and Clinical Neuroscience, Neurosurgery, Umea University, Sweden.
authors: Lars-Owe D
authors: LD
authors: Koskinen
mesh_terms: D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D000070642:Brain Injuries, Traumatic / Q000097:blood / Q000134:cerebrospinal fluid; D006801:Humans; D011379:Prognosis; D064568:S100 Calcium Binding Protein beta Subunit / Q000097:blood / Q000134:cerebrospinal fluid; D013345:Subarachnoid Hemorrhage / Q000097:blood / Q000134:cerebrospinal fluid
chemical_list: D015415:Biomarkers; D064568:S100 Calcium Binding Protein beta Subunit; C579160:S100B protein, human
keywords: Biomarker; Head injury; Prognosis; S 100B